Francisco Pasquau
Overview
Explore the profile of Francisco Pasquau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
103
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ruiz-Alguero M, Alejos B, Garcia Yubero C, Riera Jaume M, Iribarren J, Asensi V, et al.
AIDS Res Hum Retroviruses
. 2022 Mar;
38(6):433-440.
PMID: 35357907
The present study sought to describe the use of generic drugs and single-tablet regimen (STR) de-simplification for the treatment of human immunodeficiency virus (HIV) infection among 41 hospitals from the...
2.
Solans-Laque R, Fraile G, Rodriguez-Carballeira M, Caminal L, Castillo M, Martinez-Valle F, et al.
Medicine (Baltimore)
. 2017 Feb;
96(8):e6083.
PMID: 28225490
The aim of this study was to describe the clinical characteristics of ANCA-associated vasculitides (AAV) at presentation, in a wide cohort of Spanish patients, and to analyze the impact of...
3.
Ramos J, Pasquau F, Galipienso N, Valero B, Navarro A, Martinez A, et al.
J Med Case Rep
. 2015 Jul;
9:165.
PMID: 26215452
Introduction: Whipple's disease is a rare infectious disease caused by Tropheryma whipplei with protean clinical manifestations. This infection may mimic chronic inflammatory rheumatisms. Case Presentation: We report two cases of...
4.
Ena J, Pasquau F, del Mar Lopez-Perezagua M, Martinez-Peinado C, Arjona F
Pathog Glob Health
. 2014 Dec;
108(8):356-61.
PMID: 25468205
Background: We anticipated that patients with HIV infection living in endemic areas were at greater risk of infection which can reactivate due to immunosuppression; therefore, we analyzed the prevalence of...
5.
Ena J, Amador C, Benito C, Pasquau F
HIV AIDS (Auckl)
. 2012 Nov;
4:169-79.
PMID: 23172991
We reviewed the current information available on nevirapine immediate- and extended-release formulations and its role in single-dose and combination antiretroviral therapy. Nevirapine was approved in 1996 and was the first...
6.
Ena J, Ruiz-de-Apodaca R, Pasquau F, Amador C, Benito C
Eur J Intern Med
. 2011 Jan;
22(1):66-72.
PMID: 21238897
Background: Sustained virologic response to peginterferon plus ribavirin reduces liver-related complications and mortality in patients co-infected with HIV and hepatitis C virus. Therefore, the presence of any barriers to start...
7.
Ena J, F Ruiz de Apodaca R, Amador C, Benito C, Pasquau F
Enferm Infecc Microbiol Clin
. 2006 May;
24(4):232-7.
PMID: 16725082
Background: We incorporated the latest available information to evaluate the net benefit of using resistance testing in HIV-infected patients with virological failure. Methods: Meta-analysis of randomized controlled trials comparing the...
8.
Amador C, Pasquau F, Ena J, Benito C, F Ruiz de Apodaca R
Med Clin (Barc)
. 2005 Jun;
125(2):41-5.
PMID: 15970181
Background And Objective: To describe the immunological, virological and clinical outcomes of HIV-infected patients who stop antiretroviral therapy (ART) and to identify the factors related to durability. Patients And Method:...
9.
Ena J, Benito C, Llacer P, Pasquau F, Amador C
Med Clin (Barc)
. 2004 Jun;
122(19):721-6.
PMID: 15171905
Background And Objective: Dyslipidemia, insulin resistance and body fat redistribution are respectively short and long-term complications of protease inhibitor-containing antiretroviral regimens. To establish whether differences in the type of antiretroviral...
10.
Ena J, Amador C, Benito C, Fenoll V, Pasquau F
Int J STD AIDS
. 2003 Nov;
14(11):776-81.
PMID: 14624743
We examined the risk and determinants of developing severe liver toxicity in 108 HIV-infected patients showing adherence to nevirapine- and efavirenz-containing regimens. Between January 1997 and December 2000, 70 patients...